NEW YORK (GenomeWeb News) – The Hospital for Special Surgery in New York City will use a new $5.6 million grant to launch a center that will focus on using genomic medicine to study and develop new treatments for rheumatoid arthritis and systemic lupus erythematosus, HSS said today.

The hospital received the award from the Tow Foundation to establish the HSS Genomics Center, which will conduct investigations aimed at understanding the regulation and function of proteins involved in lupus and rheumatoid arthritis, and to identify genes linked to these diseases.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: Plasmodium knowlesi population genetics, oral microbiome of infants and children, and more.

The New York Times editorial board weighs in on scientific research misconduct.

The European Commission says it won't take funds from the European Research Council's budget for its new European Fund for Strategic Investment.

The case of the 'devious defecator' examines the protections of the Genetic Information Nondiscrimination Act.